Bioasis Technologies Inc.
BTI
Rang in aandelen
#39866
Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused... Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused on innovating diagnostic methods and therapeutic solutions for a range of neurological conditions. The company's primary technological asset is the xB3 platform, engineered to enable the transport of medicinal compounds across the often-impenetrable blood-brain barrier. This capability is crucial for addressing central nervous system disorders, including various brain cancers, metabolic dysfunctions, and neurodegenerative illnesses. Bioasis is actively advancing its in-house pipeline with programs such as xB3-001 for brain metastases, xB3-002 for glioblastoma, and xB3-007 for neurodegenerative diseases, all designed to offer both symptomatic relief and disease-modifying benefits. The company has also established numerous strategic alliances. These include a partnership with Aposense Limited to deliver siRNA therapeutics for CNS disorders; a collaboration with Oxyrane UK Ltd. to combine the xB3 technology with Oxyrane's OxyCAT platform for enhanced enzyme replacement therapy targeting the brain; an agreement with Janssen Biotech, Inc. for the discovery, development, and commercialization of novel products leveraging the xB3 platform; and a research and licensing deal with Neuramedy Co Ltd. to develop and market an xB3-enhanced version of their antibody, Tomaralimab. Founded in 2006, Bioasis Technologies Inc. is headquartered in New Haven, Connecticut.
Aandeelprijs
$0.00366968
Laatst gesynchroniseerd: 2024-07-23
Marktkapitalisatie
$291.42K
Verandering (1 dag)
-0.81%
Verandering (1 jaar)
1,734.84%
Land
US
Handel Bioasis Technologies Inc. (BTI)
Categorie
Healthcare
Aandelsplitsingen voor Bioasis Technologies Inc. (BTI)
Het aandeel Bioasis Technologies Inc. (symbool: BTI) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Oct 20, 2026.
Eén aandeel BTI dat vóór Oct 20, 2026 werd gekocht, staat nu gelijk aan 0 aandelen BTI.
De meest recente splitsing vond plaats op Oct 20, 2026.
Eén aandeel BTI dat vóór Oct 20, 2026 werd gekocht, staat nu gelijk aan 0 aandelen BTI.
Lijst van aandelen splitsingen
| Jaar | Splitsing | Vermenigvuldiging | Cumulatieve vermenigvuldiging |
|---|---|---|---|
| Niet genoeg gegevens voor de verstrekte datums. | |||
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aantal aandelen splitsingen | Cumulatieve vermenigvuldiging | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
